You are currently not logged in

As indicators of a pharmacological response, quantification and monitoring of PD biomarkers is of crucial importance, particularly for dose optimization studies during pre-clinical and clinical trials. Maximum information must be obtained from limited sample volumes.

The ability to quantify unbound target molecules on a nanoliter-scale platform suitable for both PK and PD analysis significantly boosts lab and instrument productivity.

Transform lab productivity, save analyst time

Multiple analytes measured in nanoliter volumes – low sample consumption

Fast development - new assays can be running within days

Fast turnaround - automation improves throughput, speeds up assay validation

Fewer dilutions - broad dynamic range and reduced matrix effects

More Information

Gyrolab xP workstation

(PDF, 827.8 kB)

Gyrolab Bioaffy CDs and Rexxip buffers

(PDF, 843.9 kB)
{h_blk_flyout_menuitem_1}

Gyros immunoassay platform

See how Gyrolab products and nanoliter-scale technology transform performance and productivity

Develop and run immunoassays at nanoliter scale:

Ready to use on Gyrolab xP workstation

Designed for use with Gyrolab CDs

Login
E-mail:
Password:
Remember me

If you do not have a Gyros website account yet:
request one here.

If you forgot your password:
request a new one.